Early lupus patient data sends Kezar Life Sciences' stock soaring after-hours
June 27, 2022 at 21:31 PM EDT
The company's stock also took a substantial dive early last month after the same drug missed its mark in two other diseases.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
